Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells

Br J Ophthalmol. 2002 Jan;86(1):97-101. doi: 10.1136/bjo.86.1.97.

Abstract

Background: Sorsby's fundus dystrophy (SFD) and age related macular degeneration (ARMD) are retinal diseases associated with a high level of accumulation of mutant and wild type TIMP-3, respectively, in Bruch's membrane. The pathogenic role of TIMP-3 in these diseases is uncertain, but causative mutations have been identified in the TIMP-3 gene of patients with SFD. Recent reports that TIMP-3 causes apoptosis in certain cell types and not in others prompted the authors to investigate whether TIMP-3 causes apoptosis in cultured retinal pigment epithelium (RPE) cells.

Methods: RPE and MCF-7 cells (as a positive control) were initially infected with replication deficient adenovirus, to overexpress beta-galactosidase (RAdLacZ) or TIMP-3 (RAdTIMP-3). TIMP-3 was detected by western blotting and ELISA. Cell viability was defined by cell counts. ISEL was used to investigate the mechanism of cell death.

Results: Cultured RPE cells produced small quantities of endogenous TIMP-3 and remained viable. However, overexpression of TIMP-3 caused a dose related death of RPE cells. The mechanism of cell death was apoptosis.

Conclusion: The previously unreported finding of TIMP-3 induced apoptosis of RPE cells may account for some of the early features seen in SFD and ARMD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Apoptosis* / physiology
  • Blotting, Western
  • Cell Count
  • Cell Line
  • Cell Survival
  • Dose-Response Relationship, Drug
  • Enzyme-Linked Immunosorbent Assay
  • Fundus Oculi
  • Genetic Therapy / methods
  • Humans
  • Macular Degeneration / genetics
  • Macular Degeneration / metabolism
  • Macular Degeneration / pathology
  • Pigment Epithelium of Eye / pathology*
  • Retinal Diseases / genetics*
  • Retinal Diseases / metabolism
  • Retinal Diseases / pathology
  • Tissue Inhibitor of Metalloproteinase-3 / administration & dosage
  • Tissue Inhibitor of Metalloproteinase-3 / genetics
  • Tissue Inhibitor of Metalloproteinase-3 / metabolism*
  • Transduction, Genetic / methods
  • Transgenes / genetics
  • Tumor Cells, Cultured

Substances

  • Tissue Inhibitor of Metalloproteinase-3